1. Home
  2. KZIA vs ZDAI Comparison

KZIA vs ZDAI Comparison

Compare KZIA & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • ZDAI
  • Stock Information
  • Founded
  • KZIA 1994
  • ZDAI 2022
  • Country
  • KZIA Australia
  • ZDAI Hong Kong
  • Employees
  • KZIA N/A
  • ZDAI N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • ZDAI General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • KZIA Health Care
  • ZDAI Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • ZDAI Nasdaq
  • Market Cap
  • KZIA 11.7M
  • ZDAI 13.5M
  • IPO Year
  • KZIA 1999
  • ZDAI 2024
  • Fundamental
  • Price
  • KZIA $8.68
  • ZDAI $0.50
  • Analyst Decision
  • KZIA Strong Buy
  • ZDAI
  • Analyst Count
  • KZIA 2
  • ZDAI 0
  • Target Price
  • KZIA $14.00
  • ZDAI N/A
  • AVG Volume (30 Days)
  • KZIA 675.5K
  • ZDAI 71.3K
  • Earning Date
  • KZIA 08-12-2025
  • ZDAI 08-15-2025
  • Dividend Yield
  • KZIA N/A
  • ZDAI N/A
  • EPS Growth
  • KZIA N/A
  • ZDAI N/A
  • EPS
  • KZIA N/A
  • ZDAI N/A
  • Revenue
  • KZIA $1,549,158.00
  • ZDAI $17,166,534.00
  • Revenue This Year
  • KZIA N/A
  • ZDAI N/A
  • Revenue Next Year
  • KZIA $49.25
  • ZDAI N/A
  • P/E Ratio
  • KZIA N/A
  • ZDAI $15.89
  • Revenue Growth
  • KZIA 248983.08
  • ZDAI 56.11
  • 52 Week Low
  • KZIA $2.86
  • ZDAI $0.37
  • 52 Week High
  • KZIA $39.05
  • ZDAI $107.36
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 50.61
  • ZDAI N/A
  • Support Level
  • KZIA $7.40
  • ZDAI N/A
  • Resistance Level
  • KZIA $10.08
  • ZDAI N/A
  • Average True Range (ATR)
  • KZIA 0.78
  • ZDAI 0.00
  • MACD
  • KZIA -0.29
  • ZDAI 0.00
  • Stochastic Oscillator
  • KZIA 42.38
  • ZDAI 0.00

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About ZDAI Primega Group Holdings Limited Ordinary Shares

Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

Share on Social Networks: